Anteilseigner
Neurocrine Biosciences (15,79 %) Armistice Capital LLC (8,60 %) EcoR1 Capital, LLC (7,21 %) The Vanguard Group, Inc. (5,80 %) BlackRock Fund Advisors (5,50 %) Farallon Capital Management LLC (4,22 %) SSgA Funds Management, Inc. (3,22 %) Dimensional Fund Advisors LP (2,04 %) BlackRock Advisors LLC (1,91 %) T. Rowe Price Associates, Inc. (Investment Management) (1,86 %) Geode Capital Management LLC (1,79 %) AQR Capital Management LLC (1,46 %) American Century Investment Management, Inc. (1,42 %) Vestal Point Capital LP (1,10 %) Federated MDTA LLC (1,02 %) Acadian Asset Management LLC (0,85 %) Northern Trust Investments, Inc.(Investment Management) (0,71 %) Bank of America, NA (Private Banking) (0,65 %) Alfred W. Sandrock,
Jr,
MD,PhD (0,59 %) GlobeFlex Capital LP (0,57 %)
Kontakt
Voyager Therapeutics Inc.